Randomized, Double Blind, Multicenter, Phase II/III Study to Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Children.
Phase of Trial: Phase II/III
Latest Information Update: 30 Jan 2015
At a glance
- Drugs GC 1107 (Primary) ; Diphtheria-tetanus vaccine
- Indications Diphtheria; Tetanus
- Focus Pharmacodynamics
- Sponsors Green Cross
- 22 Apr 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 29 Aug 2012 Actual initiation date (Aug 2011) added as reported by ClinicalTrials.gov.
- 29 Aug 2012 Planned End Date changed from 1 Dec 2011 to 1 Apr 2014 as reported by ClinicalTrials.gov.